Saturday, December 6, 2025

UN General Assembly Hosts Rare Debate on North Korea’s Human Rights Violations

The UN's first high-level meeting on North Korean human rights, with South Korean participation, spotlighted systemic violations and global concerns.

Disney & Universal Just Sued This AI Company — And It’s a Big Deal

Disney and Universal sue Midjourney for copyright infringement over unauthorized use of their iconic characters, signaling a legal precedent.

North Korea: Russian Foreign Intelligence Service Delegation Visited North Korea to Deal With Espionage Efforts

A delegation from Russia's Foreign Intelligence Service...

Tag: Novo Nordisk

North KoreaKoreaKimSouth KoreaMilitaryAImarketchinaRussia

Wegovy Gets Stronger: New Dose Promises Even More Weight Loss

Novo Nordisk's new high-dose Wegovy aims to enhance obesity treatment, with promising trial results and a strategic EU rollout planned.

Rising Use of GLP-1 Drugs May Be Linked to Rare Pancreatitis Cases, Study Finds

Reports of acute pancreatitis linked to GLP-1 diabetes drugs surge in the UK, prompting investigations and conflicting academic findings.

Ozempic Maker Swaps CEO, Bets $2.2B on New Obesity Drug Fight

Novo Nordisk's leadership change aims to reclaim its obesity treatment market share amid competition from Eli Lilly's Mounjaro.

New Study: Mounjaro Helps Users Drop Over 50 Pounds

Eli Lilly's Mounjaro leads U.S. obesity drug market, outperforming semaglutide in weight loss efficacy and safety.

Novo Nordisk Pushes for First Oral Obesity Drug Approval

Novo Nordisk seeks FDA approval for oral Wegovy, potentially the first oral obesity treatment, amid competition with Eli Lilly.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.